Kansas City, KSNCT06907199Now EnrollingIRB Ready

Recurrent UTIs Clinical Trial in Kansas City, KS

Access cutting-edge recurrent utis treatment through this clinical trial at a research site in Kansas City. Study-provided care at no cost to qualified participants.

Sponsored by University of Texas Southwestern Medical Center

Quick Self-Assessment

See if you qualify for this Kansas City location

Preparing your pre-screening questions…

Expert Care in Kansas City

Access recurrent utis specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related recurrent utis treatment provided free

Apply for This Kansas City Location

Check if you qualify for this recurrent utis clinical trial in Kansas City, KS

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Kansas City

    Convenient for KS residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Kansas City site if eligible
  4. 4Begin participation

About This Recurrent UTIs Study in Kansas City

The goal of this clinical trial is to learn if the drug Nitrofurantoin (NF) taken as a daily antibiotic, works to treat cystitis compared to electrofulguration (EF) and Nitrofurantoin (NF) daily antibiotic.

Sponsor: University of Texas Southwestern Medical Center

Who Can Participate

Inclusion Criteria

Females 18 to 85 years old with at least a 1-year history of culture documented uncomplicated rUTI.
Diagnosis of rUTI, defined as ≥ 3 symptomatic UTIs in 12 months or ≥ 2 in 6 months.
Currently free from a UTI determined based on absence of symptoms as determined by the UTI symptom assessment questionnaire and negative urine culture (\<10\^3 colony forming units per ml of urine).
A negative upper and lower urinary tract evaluation, including pelvic examination for pelvic organ prolapse (less than or equal to stage 2), measurement of post-void residual (less than 50 ml), and imaging (which may include renal ultrasound and standing voiding cystourethrogram) to exclude kidney stone, hydronephrosis, reflux, or urethral diverticulum.
Office cystoscopy documenting stages 1 or 2 of chronic cystitis.
Likely to stay in the geographic region for the duration of the study.
ASA class II or less.

Exclusion Criteria

Patients on antibiotics at baseline (i.e., suppressive therapy or antibiotic therapy for non-urinary infections).
Patients on self-start therapy (i.e., taking antibiotics upon start of urinary symptoms concerning for UTI).
Patients on prophylactic antibiotics started in the last 3 months and unwilling to discontinue, or intention to start in the next 12 months.
Complicated UTIs, including neurogenic bladder condition (i.e., multiple sclerosis, Parkinson's disease, spinal cord injury), bladder augmentation, or urinary diversion.
Patients with urinary catheters (including indwelling Foley, intermittent catheterization, and suprapubic catheters).
Uncontrolled diabetes (HbA1c \>9).
Allergy or resistance to Nitrofurantoin.
Chronic lung or liver condition precluding the use of Nitrofurantoin, including abnormal chest X ray or elevated liver function tests.
Chronic renal insufficiency (creatinine over 1.5 g/dl or GFR less than 40) precluding the use of Nitrofurantoin.
History of chronic diarrhea requiring regular therapy.
Patients with psychosis, dementia, swallowing disorders, or any other ability to take Nitrofurantoin reliably at home.
BMI over 40.
Use of Uromune or other vaccine approaches to reduce rUTI episodes
Participation in a research study involving an investigational product in the past 12 weeks.
Patients receiving phage therapy.
Current diagnosis of interstitial cystitis.
Patients with medical conditions requiring excessively large amounts of fluid intake.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Kansas City?

Yes, this clinical trial (NCT06907199) has an active research site in Kansas City, KS that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Recurrent UTIs Treatment Options in Kansas City, KS

If you're searching for recurrent utis treatment options in Kansas City, KS, this clinical trial (NCT06907199) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Kansas City research site is actively enrolling participants for this clinical trial. You'll receive care from experienced recurrent utis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all recurrent utis clinical trials near you to find additional studies recruiting in your area.

More UTI Trials in Kansas City, KS

See all uti clinical trials recruiting in Kansas City — not just this study.

Browse UTI Trials in Kansas City →

Browse More Trials by Condition

UTI TrialsAll Conditions →

Ready to Join in Kansas City?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Kansas City, KS